Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Motor neurons are specialized nerve cells located in the central nervous system, specifically within the spinal cord and brainstem, that are responsible for transmitting electrical impulses to muscles to initiate and control voluntary and involuntary movements (StatPearls, 2023). These cells are characterized by their long axons that extend to the periphery to form the neuromuscular junction, where they release neurotransmitters to trigger muscle contraction (NIH, 2024). The selective degeneration of motor neurons is the primary pathological feature of motor neuron diseases (MNDs), such as Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA) (PubMed, 2022). While 'Motor neuron cells' represent a complex biological system rather than a single molecular target, they are the focus of intensive therapeutic development aimed at neuroprotection and genetic restoration. Current pharmacological interventions involve modulating excitatory neurotransmission, reducing oxidative stress, or utilizing advanced genetic therapies to address underlying molecular defects within these cells (Nature Reviews Neurology, 2021).
Drugs associated with motor neuron diseases function through diverse mechanisms: Riluzole inhibits glutamate release and inactivates voltage-dependent sodium channels; Edaravone acts as a free radical scavenger to reduce oxidative stress; Nusinersen and Risdiplam modulate SMN2 gene splicing to increase functional SMN protein; Onasemnogene abeparvovec provides a functional copy of the SMN1 gene via viral vector; and Tofersen is an antisense oligonucleotide that mediates the degradation of SOD1 mRNA.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Motor neuron cell (MN).